Solution-Phase Peptide Synthesis Using GAP Protecting Groups
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing peptide synthesis methods face challenges in achieving high yield and purity without the use of chromatography and recrystallization, particularly due to the difficulty in removing side products like N-fluorenylmethylpiperidine (NFMP) and the high cost of alternative deprotection methods, making them economically prohibitive for commercial production.
Innovation Solution
A solution-phase peptide synthesis method using a novel benzyl-type protecting group for C-terminus protection, known as BnDppOH, BnDppYH, or BzDppOH, which allows for high yield and purity by selectively precipitating peptides, thereby avoiding chromatography and recrystallization, and is economically feasible.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional Fmoc deprotection with piperidine is used in solution-phase peptide synthesis, then the deprotection reaction proceeds efficiently, but the side product NFMP becomes difficult to remove without polymer supports, reducing purification efficiency
Solution Approach 1:
The patent introduces 4-aminomethylpiperidine (4AMP) as an intermediary reagent that reacts with the Fmoc group during deprotection to form NFMP-CH2NH2 instead of the traditional NFMP side product. This intermediary approach modifies the deprotection chemistry to produce a water-soluble byproduct that can be easily removed, resolving the contradiction between maintaining efficient deprotection and achieving easy purification without polymer supports
2Ease of manufacture
If 4-aminomethylpiperidine (4AMP) is used instead of piperidine for Fmoc deprotection to enable water-soluble side product removal, then purification becomes easier, but the cost increases significantly, reducing economic feasibility
Solution Approach 1:
The patent replaces the expensive 4AMP reagent with a cheap, readily available alternative that serves the same functional purpose of enabling water-soluble byproduct formation. This substitution maintains the purification advantage while dramatically reducing material costs, making the solution-phase synthesis economically viable for commercial production
3Ease of manufacture
If solid-phase peptide synthesis (SPPS) with polymer supports is used, then purification after each coupling step becomes facile, but the scale-up becomes difficult due to high cost and mass occupation of polymer supports
Solution Approach 1:
The patent extracts and eliminates the polymer support component from the SPPS system, transitioning to solution-phase synthesis. By removing the solid support, the method avoids the scaling limitations and high costs associated with polymer materials while maintaining effective purification through the GAP chemistry approach that generates water-soluble byproducts
4Productivity
If traditional solution-phase peptide synthesis without GAP chemistry is used, then polymer supports are avoided, but purification requires chromatography or recrystallization, increasing process complexity
Solution Approach 1:
The patent changes the chemical parameters of the deprotection reaction by using modified reagents that alter the solubility characteristics of the byproducts. This parameter change transforms the purification challenge from requiring complex chromatographic or recrystallization processes to simple filtration and washing operations, reducing process complexity while maintaining polymer-free synthesis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves over 50% yield and 99% purity of peptides like thymopentin without polymer supports, reducing costs and waste, and enabling scalable, efficient peptide synthesis.
Implementation Method 1
allows for high yield and purity by selectively precipitating peptides, thereby avoiding chromatography and recrystallization
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
Disclosed is a system and method for Fmoc/tBu solution-phase peptide synthesis including the development of a new benzyl-type GAP protecting group, and related uses thereto. This novel GAP protecting group is utilized in place of a polymer support, facilitating C to N Fmoc peptide synthesis without chromatography, recrystallization, or polymer supports. The GAP group can be added and removed in high yield.